CombiMatrix

CombiMatrix is a clinical diagnostic laboratory specializing in cytogenomic testing for prenatal diagnosis, miscarriage analysis, pediatric developmental disorders and preimplantation genetic screening (PGS). As a full-scale cytogenetic and cytogenomic laboratory, CombiMatrix offers chromosomal microarray analysis, standard and customized FISH, and high resolution karyotyping to help clinicians better care for their patients. At CombiMatrix, we pride ourselves on the clinical and molecular diagnostic expertise of our medical team, and the technical expertise of our scientists and laboratory technicians. Everyone at CombiMatrix is committed to providing you with the best care possible.
Company Growth (employees)
Type
Public
HQ
Irvine, US
Size (employees)
55 (est)-15%
CombiMatrix is headquartered in Irvine, US

Key People at CombiMatrix

Judd Jessup

Judd Jessup

President & CEO
Scott Burell

Scott Burell

CFO
Scott Gottlieb

Scott Gottlieb

Director
Robert E. Hoffman

Robert E. Hoffman

Director
Karine Hovanes

Karine Hovanes

Laboratory Director

CombiMatrix Office Locations

CombiMatrix has an office in Irvine
Irvine, US (HQ)
100 300 Goddard
Irvine, US
150 310 Goddard

CombiMatrix Data and Metrics

CombiMatrix Financial Metrics

CombiMatrix's revenue was reported to be $12.9 m in FY, 2016 which is a 28% increase from the previous period.
Numbers are in $, USD

Revenue (FY, 2016)

12.9 m

Revenue growth (FY, 2015 - FY, 2016), %

28%

Gross profit (FY, 2016)

7.1 m

Gross profit margin (FY, 2016), %

55%

Net income (FY, 2016)

(4.1 m)

EBIT (FY, 2016)

(4.1 m)

Market capitalization (26-May-2017)

16.3 m

Closing share price (26-May-2017)

5.5

Cash (31-Dec-2016)

2.7 m
CombiMatrix's current market capitalization is $16.3 m.
Numbers are in $, USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

6.4 m8 m10.1 m12.9 m

Revenue growth, %

26%25%28%

Cost of goods sold

3.5 m4.4 m5.4 m5.8 m

Gross profit

2.8 m3.6 m4.6 m7.1 m

Gross profit Margin, %

45%45%46%55%

Operating expense total

12.8 m16.8 m16.6 m17 m

EBIT

(6.4 m)(8.8 m)(6.5 m)(4.1 m)

EBIT margin, %

(100%)(109%)(65%)(32%)

Interest expense

356 k84 k79 k69 k

Interest income

5 k23 k16 k22 k

Net Income

(3.9 m)(8.7 m)(6.6 m)(4.1 m)
Numbers are in $, USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

12.3 m1 m653 k2.7 m

Accounts Receivable

Inventories

Current Assets

16 m7.9 m7.2 m7.9 m

PP&E

581 k584 k691 k597 k

Total Assets

16.8 m8.6 m7.9 m8.5 m

Accounts Payable

Current Liabilities

2.1 m1.3 m1.8 m1.8 m

Additional Paid-in Capital

95.1 m96.3 m102.7 m109.1 m

Retained Earnings

(80.4 m)(96.8 m)(102.6 m)

Total Equity

14.7 m7.1 m5.9 m6.5 m

Financial Leverage

1.1 x1.2 x1.4 x1.3 x
Numbers are in $, USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(3.9 m)(8.7 m)(6.6 m)(4.1 m)

Depreciation and Amortization

698 k317 k297 k258 k

Accounts Receivable

(723 k)(662 k)(823 k)(1.1 m)

Inventories

Accounts Payable

Cash From Operating Activities

(5.6 m)(8.6 m)(5.7 m)(3.9 m)

Purchases of PP&E

(304 k)(72 k)(157 k)

Cash From Investing Activities

(2.1 m)(2.8 m)908 k2.1 m

Long-term Borrowings

(184 k)(188 k)

Cash From Financing Activities

17.6 m132 k4.5 m3.9 m

Interest Paid

40 k
Y, 2016

Financial Leverage

1.3 x

CombiMatrix Market Value History

CombiMatrix Online and Social Media Presence

CombiMatrix Company Life and Culture

You may also be interested in